Kadsura coccinea is a traditional Chinese medicine whose roots have long been used to treat various ailments, but little is known about the efficacy of its leaves. In this study, the antidiabetic activity of K. coccinea leaf extract (KCLE) was determined, the main components of KCLE were identified using UPLC-TOF-MS, and network pharmacology and molecular docking were integrated to elucidate the antidiabetic mechanism of KCLE. The results showed that KCLE effectively increased the glucose consumption of IR-HepG2 cells through pyruvate kinase (PK) and hexokinase (HK), promoted glycogen synthesis, and inhibited α-glucosidase and α-amylase activities. KCLE also improves diabetes by regulating AKT1, TNF, EGFR, and GSK3β. These targets (especially AKT1 and TNF) have a high binding affinity with the main active ingredients of KCLE (rutin, luteolin, demethylwedelolactone, maritimetin, and polydatin). Pathway enrichment analysis showed that the antidiabetic effect of KCLE was closely related to the PI3K-Akt signaling pathway, MAPK signaling pathway, AGE-RAGE signaling pathway, and FoxO signaling pathway. These findings provide a theoretical basis for promoting the pharmacodynamic development of K. coccinea and its application in treating diabetes.
This study investigated the chemical composition, antibacterial activity and antifungal mechanisms of Cinnamomum burmannii essential oil (CBEO) obtained from leaves and branches through pilot-scale steam molecular distillation after D-borneol crystallization, focusing on its inhibitory effects against Malassezia furfur (M. furfur). GC-MS analysis identified 78 chemical constituents in CBEO, with the monoterpenoid D-borneol predominating. CBEO exhibited potent antifungal activity against M. furfur, with MIC and MFC values of 0.88 mg/mL and 1.75 mg/mL, respectively. Synergistic effects were observed when combined with ketoconazole (FICI = 0.5). At 2 × MIC concentration, CBEO suppressed 85.6% of biofilm formation (p < 0.01) as determined by crystal violet assay. SEM imaging revealed that CBEO treatment induced the formation of surface invaginations and pore structures on fungal cells. Quantitative detection of intracellular protein, nucleic acid, and ion leakage levels confirmed CBEO enhanced membrane permeability, resulting in cytoplasmic content leakage. Ergosterol binding assays confirmed cell membrane disruption (8-fold MIC increase), while UPLC quantification demonstrated dose-dependent suppression of ergosterol synthesis. Correspondingly, squalene epoxidase (SE) activity was significantly inhibited in treated cells. These findings systematically elucidate CBEO’s anti-M. furfur mechanisms, highlighting its potential as a natural antifungal agent for cosmeceutical applications.